RECURSION PHARMACEUTICALS, INC.

(RXRX)
  Report
Delayed Nasdaq  -  04:00 2022-08-16 pm EDT
12.32 USD   -4.94%
08/11Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $8 From $7, Keeps Neutral Rating
MT
08/09RECURSION PHARMACEUTICALS : Q2 Earnings Snapshot
AQ
08/09RECURSION PHARMACEUTICALS : Provides Business Updates and Reports Second Quarter 2022 Financial Results - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart RECURSION PHARMACEUTICALS, INC.
Upcoming events on RECURSION PHARMACEUTICALS, INC.
11/09/22 Q3 2022 Earnings Release (Projected)
03/22/23 FY 2022 Earnings Release (Projected)
05/10/23 Q1 2023 Earnings Release (Projected)
08/10/23 Interim 2023 Earnings Release (Projected)
Past events on RECURSION PHARMACEUTICALS, INC.
08/09/22 | 04:15pm Interim 2022 Earnings Release
08/08/22 KeyBanc Technology Leadership Forum
06/28/22 Morgan Stanley Putting the Tech in Biotech Conference
06/14/22 | 02:00pm Annual General Meeting
06/13/22 Goldman Sachs Global Healthcare Conference
06/08/22 Jefferies Healthcare Conference
05/10/22 | 04:29pm Q1 2022 Earnings Release
05/10/22 Bank of America Healthcare Conference
04/26/22 Berenberg Discover AI Seminar
04/11/22 Needham Virtual Healthcare Conference
Past dividends on RECURSION PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December202020212022
Sales
M $
Released
Forecast
Spread
3,96

 
10,2
12,4
-18%
 
46,9
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-174
-175
0,11%
 
-257
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-183
-174
-4,9%
 
-233
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-186
-163
-14%
 
-245
 
Net income
M $
Released
Forecast
Spread
-87,0

 
-186
-177
-5,5%
 
-223
 
EPS
$
Released
Forecast
Spread
-5,99

 
-1,49
-1,20
-24%
 
-1,54
 
Announcement Date03/03/202103/23/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
2,55
2,73
-6,5%
2,53
2,70
-6,1%
2,53
6,07
-58%
5,33
84,0
-94%
7,67
5,40
42%
 
7,13
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-40,9
-36,4
-12%
-46,4
-45,9
-1,1%
-65,0
-48,5
-34%
-56,0
-52,0
-7,7%
-66,2
-65,6
-0,92%
 
-66,9
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-43,4
-34,0
-28%
-47,4
-43,2
-9,9%
-64,9
-43,0
-51%


 
-65,6
-57,0
-15%
 
-61,0
 
Net income
M $
Released
Forecast
Spread
-43,4
-34,0
-28%
-47,4
-46,2
-2,6%
-64,9
-50,0
-30%
-56,0
87,3
-164%
-65,6
-60,6
-8,3%
 
-63,1
 
EPS
$
Released
Forecast
Spread
-0,31
-0,23
-34%
-0,28
-0,28
0,23%
-0,38
-0,30
-28%
-0,33
0,51
-165%
-0,38
-0,35
-10%
 
-0,37
 
Announcement Date08/13/202111/10/202103/23/202205/10/202208/09/2022-
Previous year Next Year
Upcoming sector events for RECURSION PHARMACEUTICALS, INC.
More events
Past sector events for RECURSION PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise